Pacelli A, Bostwick D G
Department of Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Urology. 1997 Sep;50(3):355-9. doi: 10.1016/S0090-4295(97)00249-5.
High-grade prostatic intraepithelial neoplasia (PIN) is the most likely precursor of invasive prostatic adenocarcinoma. The incidence and clinical significance of this lesion have not been previously defined in specimens from transurethral resections of the prostate (TURP).
To determine the frequency of PIN in TURP specimens and its relationship with adenocarcinoma, we reviewed 698 resections performed at Mayo Clinic between 1989 and 1990. A mean of 6 slides was analyzed for each case (range 1 to 36). The presence, extent, and architectural pattern of PIN were recorded. The results were correlated with many clinical and pathologic features, including patient age, Gleason score, stage, serum prostate-specific antigen (PSA) concentration, and patient follow-up. In a 1:2 nested matching case-control study, we compared the outcome of cases with PIN alone with that of the control group. Each patient with PIN alone (16 patients) was matched randomly with 2 patients with benign prostatic hyperplasia (BPH) alone (32 patients) according to age (+/- 5 years) and serum PSA concentration (+/- 1 ng/mL).
Of 698 TURP specimens, 570 (81.7%) contained BPH and 128 (18.3%) contained adenocarcinoma and BPH. High-grade PIN was identified in 29 cases (4.2%), including 16 (2.8%) of those with BPH and 13 (10.2%) of those with cancer and BPH. Follow-up revealed adenocarcinoma in 3 of 14 patients (21.4%) with PIN and BPH only after 3, 5, and 7 years, respectively; mean follow-up for the 14 patients was 6 years (range 4 to 7 years), and none of the patients died of prostate cancer. Conversely, none of the patients (0%) without PIN in TURP specimens in the case-control study had subsequent adenocarcinoma.
The overall incidence of PIN in TURP specimens was 4.2%, including 2.8% without cancer and 10.2% with coexistent cancer. Prostatic adenocarcinoma was diagnosed within 7 years in 21.4% of patients with PIN in TURP specimen. Conversely, none of those without PIN matched for age and serum PSA had adenocarcinoma at follow-up. These results indicate that high-grade PIN is uncommon in TURP specimens and, when found, indicates a significant risk of cancer. The presence of PIN in TURP specimens should be reported by the pathologist; in addition, the entire specimen should be submitted for histologic examination to exclude carcinoma.
高级别前列腺上皮内瘤变(PIN)是浸润性前列腺腺癌最可能的前驱病变。此前,经尿道前列腺切除术(TURP)标本中该病变的发生率及临床意义尚未明确。
为确定TURP标本中PIN的发生率及其与腺癌的关系,我们回顾了1989年至1990年间在梅奥诊所进行的698例切除术。每例平均分析6张玻片(范围为1至36张)。记录PIN的存在、范围及结构模式。将结果与许多临床和病理特征相关联,包括患者年龄、Gleason评分、分期、血清前列腺特异性抗原(PSA)浓度及患者随访情况。在一项1:2巢式匹配病例对照研究中,我们比较了单纯PIN病例与对照组的结果。每例单纯PIN患者(16例)根据年龄(±5岁)和血清PSA浓度(±1 ng/mL)与2例单纯良性前列腺增生(BPH)患者(32例)随机匹配。
在698例TURP标本中,570例(81.7%)含有BPH,128例(18.3%)含有腺癌和BPH。29例(4.2%)发现高级别PIN,其中单纯BPH患者中有16例(2.8%),合并癌症和BPH患者中有13例(10.2%)。随访发现,仅患有PIN和BPH的14例患者中,分别在3年、5年和7年后有3例(21.4%)发生腺癌;这14例患者的平均随访时间为6年(范围4至7年),且无一例患者死于前列腺癌。相反,病例对照研究中TURP标本中无PIN的患者无一例后续发生腺癌。
TURP标本中PIN的总体发生率为4.2%,其中无癌症者为2.8%,合并癌症者为10.2%。TURP标本中有PIN的患者中,21.4%在7年内被诊断为前列腺腺癌。相反,年龄和血清PSA匹配但无PIN的患者在随访中无一例发生腺癌。这些结果表明,高级别PIN在TURP标本中并不常见,一旦发现则提示有显著的癌症风险。病理学家应报告TURP标本中PIN的存在情况;此外,应提交整个标本进行组织学检查以排除癌。